Søgeord (covid) valgt.
32 emner vises.
1
EARLY RELEASE: Vital Signs: Drowning Death Rates, Self-Reported Swimming Skill, Swimming Lesson Participation, and Recreational Water Exposure - United States, 2019-2023
Morbidity and Mortality Weekly Report (MMWR), 14.05.2024
Tilføjet 14.05.2024
This report describes drowning death rates before and after the COVID-19 pandemic.
Læs mere
2
COVID Vaccines and New-Onset Seizures: New Data
Medscape Infectious Diseases, 8.05.2024
Tilføjet 8.05.2024
There is no link between the SARS-CoV-2 vaccine and increased risk for new-onset seizure activity, results from a new meta-analysis showed. Medscape Medical News
Læs mere
3
mRNA Vaccines: Not Just for COVID Soon?
Medscape Infectious Diseases, 2.05.2024
Tilføjet 2.05.2024
The mRNA technology enables quick and flexible responses to new variants of pathogens and rapid scale-up in production, said one researcher. Medscape Medical News
Læs mere
4
Flu vs COVID: Stark Disparity in Vaccination and Deaths
Medscape Infectious Diseases, 2.05.2024
Tilføjet 2.05.2024
Despite safety and effectiveness, COVID vaccination rates remained lower than flu vaccination rates — and resulting death rates put this in a grim light. Medscape Medical News
Læs mere
5
Two Biosimilars Approved in Europe for Autoimmune Disorders
Medscape Infectious Diseases, 26.04.2024
Tilføjet 26.04.2024
The drugs are intended to treat several types of arthritis, psoriasis, COVID-19, and Crohn\'s disease. Medscape Medical News
Læs mere
6
Use of an Additional Updated 2023-2024 COVID-19 Vaccine Dose for Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024
Morbidity and Mortality Weekly Report (MMWR), 26.04.2024
Tilføjet 26.04.2024
This report describes a recommendation from the Advisory Committee on Immunization Practices that all people ages ≥65 years and older receive one additional dose of any updated (2023-2024 Formula) COVID-19 vaccine.
Læs mere
7
SARS-CoV-2 Viral Shedding and Rapid Antigen Test Performance - Respiratory Virus Transmission Network, November 2022-May 2023
Morbidity and Mortality Weekly Report (MMWR), 26.04.2024
Tilføjet 26.04.2024
This report describes the sensitivity of different kinds of tests that detect SARS-CoV-2, the virus that causes COVID-19.
Læs mere
8
Malariavacciner er et lille lyspunkt i en dyster udvikling
Statens Serum Institut, 25.04.2024
Tilføjet 25.04.2024
Bekæmpelsen af malaria er i de senere år gået den forkerte vej. Det skyldes blandt andet øget resistens, følger af covid-19-pandemien, de globale klimaforandringer og faldende finansiering til malariabekæmpelse. Introduktionen af de første malariavacciner i mange afrikanske lande i 2024 er et lille lyspunkt.
Læs mere
9
Long COVID Rates Elevated in Men With Type 2 Diabetes
Medscape Infectious Diseases, 24.04.2024
Tilføjet 24.04.2024
The opposite was seen in women when compared with matched control individuals without diabetes. Medscape UK
Læs mere
10
Vaccine-Preventable Diseases Surge: Europe Sounds the Alarm
Medscape Infectious Diseases, 23.04.2024
Tilføjet 23.04.2024
ECDC data show that measles and pertussis cases are on the rise again after a post–COVID-19 pandemic decline. Medscape Medical News
Læs mere
11
COVID-19 Vaccination Coverage, and Rates of SARS-CoV-2 Infection and COVID-19-Associated Hospitalization Among Residents in Nursing Homes - National Healthcare Safety Network, United States, October 2023-February 2024
Morbidity and Mortality Weekly Report (MMWR), 19.04.2024
Tilføjet 19.04.2024
This report describes COVID-19 rates, hospitalizations, and vaccination coverage among nursing home residents.
Læs mere
12
Durability of Original Monovalent mRNA Vaccine Effectiveness Against COVID-19 Omicron-Associated Hospitalization in Children and Adolescents - United States, 2021-2023
Morbidity and Mortality Weekly Report (MMWR), 19.04.2024
Tilføjet 19.04.2024
This report describes the duration of protection provided by the original monovalent COVID-19 vaccines.
Læs mere
13
After COVID, WHO Defines Disease Spread 'through Air'
Medscape Infectious Diseases, 18.04.2024
Tilføjet 18.04.2024
The World Health Organization and around 500 experts have agreed for the first time what it means for a disease to spread through the air, in a bid to avoid the confusion... Reuters Health Information
Læs mere
14
Surveillance of COVID-19 in long-term care facilities in the EU/EEA 2021-2023
ECDC
ECDC COVID-19 updates, 17.04.2024
Tilføjet 17.04.2024
This report collects all COVID-19 long-term care facilities (LTCF) data reported to ECDC from 2021 and concludes the EU/EEA LTCF COVID-19 specific surveillance data collection from 2021-2023.
Læs mere
15
4 Years In, a Sobering Look at Long COVID Progress
Medscape Infectious Diseases, 16.04.2024
Tilføjet 16.04.2024
Where long COVID treatment and research is right now — and where it\'s going. Medscape Medical News
Læs mere
16
COVID Vaccinations Less Prevalent in Marginalized Patients
Medscape Infectious Diseases, 15.04.2024
Tilføjet 15.04.2024
Primary care doctors who serve marginalized communities had the highest rate of patients unvaccinated against COVID-19 in a recent study. Medscape Medical News
Læs mere
17
Communicable disease threats report, 7 - 13 April 2024, week 15
ECDC
ECDC COVID-19 updates, 12.04.2024
Tilføjet 12.04.2024
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 7 - 13 April 2024 and includes updates on measles, avian influenza, COVID-19, Mpox, seasonal influenza, RSV, cholera and shigellosis.
Læs mere
18
Communicable disease threats report, 7 - 13 April 2024, week 15
ECDC
ECDC Communicable Disease Threats Report, 12.04.2024
Tilføjet 12.04.2024
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 7 - 13 April 2024 and includes updates on measles, avian influenza, COVID-19, Mpox, seasonal influenza, RSV, cholera and shigellosis.
Læs mere
19
Excess mortality in Europe coincides with peaks of COVID-19, influenza and respiratory syncytial virus (RSV), November 2023 to February 2024
Sarah K Nørgaard, Jens Nielsen, Anne Christine Nordholm, Lukas Richter, Alena Chalupka, Natalia Bustos Sierra, Toon Braeye, Maria Athanasiadou, Theodore Lytras, Gleb Denissov, Oskari Luomala, Anne Fouillet, Isabelle Pontais, Matthias an der Heiden, Benedikt Zacher, Alina Weigel, Ivo Foppa, Kassiani Gkolfinopoulou, Ioannis Panagoulias, Anna Paldy, Tibor Malnasi, Lisa Domegan, Eva Kelly, Naama Rotem, Oksana Rakhlin, Francesca K de'Donato, Chiara Di Blasi, Patrick Hoffmann, Telma Velez, Kathleen England, Neville Calleja, Liselotte van Asten, Femke Jongenotter, Ana Paula Rodrigues, Susana Silva, Petra Klepac, Diana Gomez-Barroso, Inmaculada Leon Gomez, Ilias Galanis, Ahmed Farah, Rolf Weitkunat, Katarina Fehst, Nick Andrews, Tom Clare, Declan T Bradley, Mark G O'Doherty, Naoma William, Mark Hamilton, Bolette Søborg, Tyra G Krause, Nick Bundle and Lasse S Vestergaard
Eurosurveillance latest updates, 12.04.2024
Tilføjet 12.04.2024
Since the end of November 2023, the European Mortality Monitoring Network (EuroMOMO) has observed excess mortality in Europe. During weeks 48 2023–6 2024, preliminary results show a substantially increased rate of 95.3 (95% CI: 91.7–98.9) excess all-cause deaths per 100,000 person-years for all ages. This excess mortality is seen in adults aged 45 years and older, and coincides with widespread presence of COVID-19, influenza and respiratory syncytial virus (RSV) observed in many European countries during the 2023/24 winter season.
Læs mere
20
Assessment of Risk for Sudden Cardiac Death Among Adolescents and Young Adults After Receipt of COVID-19 Vaccine - Oregon, June 2021-December 2022
Morbidity and Mortality Weekly Report (MMWR), 12.04.2024
Tilføjet 12.04.2024
This report describes a review of Oregon death certificate data to assess whether young people in Oregon might be dying after receiving a COVID-19 vaccine.
Læs mere
21
COVID-19 Vaccination Coverage - World Health Organization African Region, 2021-2023
Morbidity and Mortality Weekly Report (MMWR), 12.04.2024
Tilføjet 12.04.2024
This report describes COVID-19 vaccination coverage in the World Health Organization African Region during 2021-2023.
Læs mere
22
Interim analysis of COVID-19 vaccine effectiveness against hospitalisation due to COVID-19 and death using electronic health records in eight European countries: first update
ECDC
ECDC COVID-19 updates, 8.04.2024
Tilføjet 8.04.2024
This report presents pooled COVID-19 vaccine effectiveness (VE) estimates for the first, second and third booster doses (compared to complete primary vaccination with no booster) against hospitalisation due to COVID-19 and COVID-19-related death in resident populations ≥50 years of age living in the community.
Læs mere
23
For Some MDs, Long COVID Burnout Is a New Reality
Medscape Infectious Diseases, 5.04.2024
Tilføjet 5.04.2024
Pandemic burnout has persisted with doctors just as long COVID has with patients, with some reluctant to seek treatment. Medscape Medical News
Læs mere
24
The approach to developing Ireland’s first national health protection strategy and lessons learnt, December 2021 to October 2022
Ciara Kelly, Joan Gallagher, Lola Odewumi, Robert Conway, Mary E Black, Kristin Concannon, Louise Marron and Lorraine Doherty
Eurosurveillance latest updates, 5.04.2024
Tilføjet 5.04.2024
The COVID-19 pandemic highlighted the importance of strengthening health protection worldwide. To address this as a public health priority in Ireland, between December 2021 and October 2022 the first national Health Protection Strategy (2022–2027) for the Irish Health Service Executive (HSE) was developed. We describe the approach taken to develop a first national health protection strategy for Ireland, and highlight the key lessons learned. Key steps in strategy formation included detailed stakeholder analysis, exploration of the context for the strategy and development of a comprehensive consultation plan. Two stakeholder consultation workshops were held. The first focused on defining strategic vision, aim and objectives, the second verified objectives and identified enablers. A subsequent e-consultation invited feedback from wider stakeholders. The published strategy outlines 10 strategic objectives and 11 enablers. Key lessons identified from the strategy development process include the importance of clear leadership and oversight, the value of identifying the context for change, ensuring adequate consultation planning, taking a multidisciplinary approach with strong stakeholder engagement and the need to maintain a strategic perspective. Lessons from our experience can support colleagues internationally to strategically set out their priorities for health protection beyond COVID-19.
Læs mere
25
Federal Retail Pharmacy Program Contributions to Bivalent mRNA COVID-19 Vaccinations Across Sociodemographic Characteristics - United States, September 1, 2022-September 30, 2023
Morbidity and Mortality Weekly Report (MMWR), 5.04.2024
Tilføjet 5.04.2024
This report describes the number of COVID-19 bivalent vaccine doses administered by Federal Retail Pharmacy Program partners.
Læs mere
26
Paxlovid Not Effective for COVID-19 Symptom Relief
Medscape Infectious Diseases, 5.04.2024
Tilføjet 5.04.2024
Clinicians should still consider prescribing the drug to adults over age 65 or those who are immunocompromised, experts said. Medscape Medical News
Læs mere
27
The ED Sailed Smoothly in the Early COVID-19 Days
Medscape Infectious Diseases, 1.04.2024
Tilføjet 1.04.2024
The findings of this study, which focused on the early phases of the COVID-19 pandemic, may be useful to administrators and policymakers in case of a future pandemic outbreak. Medscape Medical News
Læs mere
28
COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022
Charlotte Lanièce Delaunay, Iván Martínez-Baz, Noémie Sève, Lisa Domegan, Clara Mazagatos, Silke Buda, Adam Meijer, Irina Kislaya, Catalina Pascu, AnnaSara Carnahan, Beatrix Oroszi, Maja Ilić, Marine Maurel, Aryse Melo, Virginia Sandonis Martín, Camino Trobajo-Sanmartín, Vincent Enouf, Adele McKenna, Gloria Pérez-Gimeno, Luise Goerlitz, Marit de Lange, Ana Paula Rodrigues, Mihaela Lazar, Neus Latorre-Margalef, Gergő Túri, Jesús Castilla, Alessandra Falchi, Charlene Bennett, Virtudes Gallardo, Ralf Dürrwald, Dirk Eggink, Raquel Guiomar, Rodica Popescu, Maximilian Riess, Judit Krisztina Horváth, Itziar Casado, Mª del Carmen García, Mariëtte Hooiveld, Ausenda Machado, Sabrina Bacci, Marlena Kaczmarek, Esther Kissling and on behalf of the European Primary Care Vaccine Effectiveness Group
Eurosurveillance latest updates, 29.03.2024
Tilføjet 29.03.2024
BackgroundScarce European data in early 2021 suggested lower vaccine effectiveness (VE) against SARS-CoV-2 Omicron lineages than previous variants. AimWe aimed to estimate primary series (PS) and first booster VE against symptomatic BA.1/BA.2 infection and investigate potential biases. MethodsThis European test-negative multicentre study tested primary care patients with acute respiratory symptoms for SARS-CoV-2 in the BA.1/BA.2-dominant period. We estimated PS and booster VE among adults and adolescents (PS only) for all products combined and for Comirnaty alone, by time since vaccination, age and chronic condition. We investigated potential bias due to correlation between COVID-19 and influenza vaccination and explored effect modification and confounding by prior SARS-CoV-2 infection. ResultsAmong adults, PS VE was 37% (95% CI: 24–47%) overall and 60% (95% CI: 44–72%), 43% (95% CI: 26–55%) and 29% (95% CI: 13–43%)
Læs mere
29
Atypical age distribution and high disease severity in children with RSV infections during two irregular epidemic seasons throughout the COVID-19 pandemic, Germany, 2021 to 2023
Wei Cai, Sophie Köndgen, Kristin Tolksdorf, Ralf Dürrwald, Ekkehard Schuler, Barbara Biere, Brunhilde Schweiger, Luise Goerlitz, Walter Haas, Thorsten Wolff, Silke Buda and Janine Reiche
Eurosurveillance latest updates, 29.03.2024
Tilføjet 29.03.2024
BackgroundNon-pharmaceutical interventions (NPIs) during the COVID-19 pandemic affected respiratory syncytial virus (RSV) circulation worldwide. AimTo describe, for children aged
Læs mere
30
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions - VISION Network, September 2023-February 2024
Morbidity and Mortality Weekly Report (MMWR), 29.03.2024
Tilføjet 29.03.2024
This report describes the effectiveness of the updated COVID-19 vaccine in preventing hospitalizations in adults with immunocompromising conditions.
Læs mere
31
New Data: Long COVID Cases Surge
Medscape Infectious Diseases, 28.03.2024
Tilføjet 28.03.2024
A post-winter rise in estimated long COVID cases may last well into 2024, experts said. Medscape Medical News
Læs mere
32
No Increased Stroke Risk After COVID-19 Bivalent Vaccine
Medscape Infectious Diseases, 28.03.2024
Tilføjet 28.03.2024
There is no increased risk for stroke during the 6 weeks following receipt of either brand of the COVID-19 bivalent vaccine, new research shows. Medscape Medical News
Læs mere